Members of the Haringey branch of the Alzheimer's Society are shocked to hear that the National Institute for Health and Clinical Excellence (Nice) has rejected the views of thousands of people by failing to reconsider its proposal to withdraw Alzheimer drug treatments from the NHS.
More than 8,000 people wrote to Nice following the publication of the draft guidance issued in March.
It was an unprecedented response. But despite being overwhelmed with personal and professional testimonies highlighting the benefits of these drugs, Nice has decided to prolong the uncertainty for people with dementia and their carers whilst it re-examines the facts.
The Alzheimer's Society believes there is overwhelming evidence which clearly states that these drugs work and, at just £2.50 a day, are good value for money.
Why won't Nice listen?
Maggie Weatherby
Haringey branch, Alzheimer's Society
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article